FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:221 January 20, 1994 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pezzella, F.

To the Editor: The potential value of the expression of bcl-2 protein as a diagnostic tumor marker and prognostic indicator in non-small-cell lung carcinoma, as described by Pezzella et al. (Sept. 2 issue),¹ may be severely limited. The fact that bcl-2 protein was expressed in only 20 percent of their total group of 122 patients and in only 12 percent of patients with adenocarcinoma indicates that this approach is not sensitive enough to be of practical use as a diagnostic screening marker for early lung cancer. Furthermore, the low rate of bcl-2 expression also suggests that this marker is unlikely . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.